4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000950170-24-074985
Director acquired 33,150 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Duncan Barbara Gayle Director | 2024-06-16 | Option exercise | +33,150 | 33,150 | D | ||
| Derivatives | |||||||
| Duncan Barbara Gayle Director | 2024-06-16 | Option exercise · Restricted Stock Units | −33,150 | 0 | D | ||
Loading xslF345X05/ownership.xml…